Online tool shows co-payments for cyclosporine

December 14, 2010

Allergan has launched a new digital tool designed to help eye-care professionals determine patient co-payments when prescribing cyclosporine ophthalmic emulsion 0.05% (Restasis) to manage dry eye.

Irvine, CA-Allergan has launched a new digital tool designed to help eye-care professionals determine patient co-payments when prescribing cyclosporine ophthalmic emulsion 0.05% (Restasis) to manage dry eye.

Using a computer or smartphone, ophthalmologists and other eye-care professionals can enter a patient’s ZIP code and then obtain the average co-pay for the health plans that have the biggest enrollments in the geographic area.

The tool is available at www.restasiscopay.com.